Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Filtering surgery with 5-fluorouracil: a second course.

A Ophir1, U Ticho

  • 1Department of Ophthalmology, Hadassah University Hospital, Jerusalem, Israel.

Eye (London, England)
|January 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An uncommon pattern of polyneuropathy induced by lifetime exposures to drift containing organophosphate pesticides.

Neurotoxicology·2014
Same author

Vitreous traction and epiretinal membranes in diabetic macular oedema using spectral-domain optical coherence tomography.

Eye (London, England)·2010
Same author

Extrafoveal vitreous traction associated with diabetic diffuse macular oedema.

Eye (London, England)·2009
Same author

Cystoid foveal oedema in symptomatic inner lamellar macular holes.

Eye (London, England)·2008
Same author

Protection of the conjunctival flap from contact with mitomycin C during tunnel-trabeculectomy.

Eye (London, England)·2006
Same author

Diabetic vitreopapillary traction and macular oedema.

Eye (London, England)·2004
Same journal

Eyelid margin tick masquerading as a naevus in a child.

Eye (London, England)·2026
Same journal

Full-thickness macular penetration by welding laser injury.

Eye (London, England)·2026
Same journal

Incidence and characteristics of newly formed polypoidal lesions in polypoidal choroidal vasculopathy.

Eye (London, England)·2026
Same journal

Traumatic intravitreal egg-shaped hematoma.

Eye (London, England)·2026
Same journal

Rare ocular triad: Goldenhar syndrome with Duane retraction syndrome and optic disc pit.

Eye (London, England)·2026
Same journal

AS-OCT demonstration of anterior capsular delamination in unilateral true exfoliation.

Eye (London, England)·2026
See all related articles

Repeat filtering surgery with 5-Fluorouracil (5-FU) injections effectively managed refractory glaucoma in five patients, lowering intraocular pressure (IOP) to 20 mmHg or less. This approach offers a favorable surgical option for challenging glaucoma cases.

Area of Science:

  • Ophthalmology
  • Glaucoma Research
  • Surgical Innovation

Background:

  • Filtering surgery is a common glaucoma treatment.
  • Filtering bleb scarring can lead to surgical failure.
  • Refractory glaucoma requires advanced treatment strategies.

Purpose of the Study:

  • To evaluate the efficacy of repeated filtering surgery combined with 5-Fluorouracil (5-FU) injections.
  • To assess the long-term intraocular pressure (IOP) control in patients with failed initial surgery.
  • To determine the safety and effectiveness of this combined approach in refractory glaucoma.

Main Methods:

  • Five patients with refractory glaucoma underwent repeat filtering surgery.
  • Subconjunctival injections of 5-Fluorouracil (5-FU) were administered post-surgery.

Related Experiment Videos

  • Follow-up ranged from 6 to 19 months, monitoring IOP levels.

    • Main Results:

    • All five patients achieved an IOP of 20 mmHg or less with medication.
    • Successful IOP control was maintained throughout the follow-up period.
    • No significant complications were reported.

    Conclusions:

    • Repeated filtering surgery with 5-FU injections is a viable and effective treatment for refractory glaucoma.
    • This therapeutic approach can overcome filtering bleb scarring and restore IOP control.
    • Further studies are warranted to confirm these findings in larger cohorts.